Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Sherman Oaks. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Sherman Oaks at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Sponsor: Neurocrine Biosciences
Check if you qualify for this schizophrenia clinical trial in Sherman Oaks, CA
If you're searching for schizophrenia treatment options in Sherman Oaks, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sherman Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.